Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Intermittent ESP Block via Subcutaneous Port for Lung Cancer Pain

Official title: Efficacy of Intermittent Erector Spinae Plane Block Via Subcutaneous Port for Cancer-Related Pain in Patients With Lung Cancer

Run by Hanoi Medical University · NCT07396558 · Data updated 2026-11-12

This study tests whether giving intermittent erector spinae plane (ESP) blocks through a subcutaneous port can better control chest wall–related cancer pain in adults with advanced lung cancer.

More Cancer Pain trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment180 (estimated)
SponsorHanoi Medical University
Academic / other
Drugs / interventionsradiation
Locations1 site (Hanoi)
StatusRecruiting
StartedMarch 1, 2026
Main results expectedSeptember 1, 2027
Study endsDecember 31, 2027
Registry record updatedSeptember 17, 2026
Trial IDNCT07396558 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with advanced lung cancer and chronic localized chest pain who are already in palliative care and can have a subcutaneous port placed.

Probably not a fit

Patients without chest-wall or thoracic pain or those unlikely to benefit from regional analgesia may not experience improvement.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study evaluates the feasibility, safety, and effectiveness of delivering local anesthetic for cancer pain using an intermittent ESP block through a subcutaneous port. Eligible participants have advanced lung cancer with chronic thoracic pain and inadequate relief from standard analgesics. Pain intensity, analgesic needs, patient comfort, and adverse events are monitored over time to determine if this approach can improve multimodal pain management.

Why it matters

Potential benefit: If successful, patients may experience better pain relief and reduced reliance on systemic opioids.

How similar studies have gone: Regional anesthesia approaches for cancer pain have shown benefits in some settings, but the specific port-delivered intermittent ESP block for lung cancer pain is exploratory.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria

* Adult patients diagnosed with advanced-stage lung cancer who are currently receiving palliative care only.
* Presence of chronic cancer-related chest pain lasting longer than 1 month, localized to the thoracic region due to chest wall invasion, pleural involvement, or bone metastases.
* Performance status ≤ 3 according to the Eastern Cooperative Oncology Group (ECOG), allowing placement of a subcutaneous port and maintenance of local anesthetic administration.
* Inadequate pain control with conventional analgesic therapies or clinical indication for the addition of regional analgesia.
* Ability to understand the study procedures and provide written informed consent after receiving a full explanation of the intervention.

Exclusion Criteria:

* Chest pain with radiation to the upper extremities, neck, or shoulder, suggestive of non-localized thoracic pain.
* Severe hepatic or renal dysfunction, or severe heart failure (New York Heart Association class III-IV).
* Local infection at the injection or port placement site, or uncontrolled systemic infection.
* Severe cachexia or insufficient subcutaneous tissue that does not allow safe coverage of the subcutaneous port.
* Known allergy to amide-type local anesthetics or other contraindications to regional anesthesia.
* Severe cognitive impairment, altered consciousness, or inability to cooperate with post-intervention monitoring.
* Lack of adequate caregiver support for home-based follow-up after discharge or inability to coordinate follow-up with local healthcare facilities.
* Severe coagulation disorders, defined as:

  * International normalized ratio (INR) \> 1.5
  * Activated partial thromboplastin time (aPTT) \> 40 seconds
  * Fibrinogen \< 1.5 g/L
  * Platelet count \< 50 × 10⁹/L.

Where it's running

  • Hanoi Medical University
    Hanoi, Vietnam
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.